trending Market Intelligence /marketintelligence/en/news-insights/trending/RGgq2Y7ABPFVjLeXQAR3fw2 content esgSubNav
In This List

Liquidia Technologies closes $31.7M common stock offering

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Liquidia Technologies closes $31.7M common stock offering

Liquidia Technologies Inc. completed an underwritten public offering of 3 million common shares to raise about $31.7 million in net proceeds.

The Morrisville, N.C.-based biopharmaceutical company priced the shares at $11.50 each and gave underwriters an option to buy up to an additional 450,000 shares.

Jefferies and Cowen were joint book-running managers, while Needham & Co. and Wedbush PacGrow were co-managers for the offering.

Liquidia develops human therapeutics using its proprietary print technology, a particle engineering platform. Its lead product candidate LIQ861 — an inhaled dry powder formulation of treprostinil — is in a phase 3 study to treat pulmonary arterial hypertension.